Clinical TrialsSearch results
Number of results: 284
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase II study of percutaneous osteoplasty for painful malignant bone tumor (JIVROSG-0703)
- Malignant vertebral and pelvic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)
- Malignant lung tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)
- malignant renal tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-04-22
Other
- A phase II study of stent therapy for malignant vena cava syndrome. (JIVROSG-0402)
- Malignant vena cava stenosis.
- Japan Interventional Radiology in Oncology Study Group(JIVROSG)
- 2005-08-07
Other
- A phase II study of the Cladribine and Rituximab combination therapy for relapsed and refractory indolent B-cell Non-Hodgkin's Lymphoma.
- low grade B cell lymphoma
- refractory lymphoma treatment study group
- 2008-12-18
Other
- A phase II trial of targeted busulfan and cyclophosphamide conditioning for allogeneic hematopoietic stem cell transplantation for hematological malignancies
- Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
- Nagoya Blood and Marrow Transplantation Group
- 2005-09-13
Other
- A phase III study of RO7030816(mosunetuzumab) in patients with follicular lymphoma after at least one line of systemic therapy
- FOLLICULAR LYMPHOMA AFTER AT LEAST ONE LINE OF SYSTEMIC THERAPY
- Enkhee Purev
- 2021-08-06
Recruiting
- A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER+/HER2- Early Breast Cancer
- Breast Cancer, Early Breast Cancer
- Hibi Kazushige
- 2023-05-26
Other
- A prospective non-randomised phase II study to assess the safety and efficacy of melphalan combined with fludarabine as a reduced conditioning regimen for unrelated bone marrow transplantation for hematological malignancies (C-SHOT 0505)
- Acute myeloid leukemia, Acute lymphocytic leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome, Chronic myelomonocytic leukemia
- Nagoya Blood and Marrow Transplantation Group
- 2006-07-31
Other
- A prospective observation study concerning the incidence of atherothrombotic events in patients with acute coronary syndrome.
- Acute coronary syndrome
- Sanofi K.K.
- 2008-05-10